‘Dream come true’: study suggests drug could extend women’s fertility by five years

Co-lead says rapamycin can be repurposed to slow ovaries from ageing and is safe for younger women

• Why sex bias in labs means women are the losers in research into ageing

A drug that could extend women's fertility by five years - and help them live longer in better health - is safe for a young, healthy population, according to early results of a study.

The research into repurposing the immunosuppressant rapamycin has been hailed a paradigm shift" in how menopause is studied.